|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.530 USD | -1.66% |
|
+5.41% | -2.36% |
| 05-12 | Harvard Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-12 | Harvard Bioscience, Inc., Q1 2026 Earnings Call, May 12, 2026 |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 7.24 | 7.87 | 7.61 |
| Spread/Res. | -9.81% | -17.03% | -14.19% |
| Spread/Supp. | +30.60% | +51.51% | +72.16% |
| Support | 5 | 4.31 | 3.793 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- HBIO Stock
- Charts Harvard Bioscience, Inc.
Select your edition
All financial news and data tailored to specific country editions
